EUVIMEDEUVIMED entdecken
Crossref

Reducing short-acting beta-2 agonist overuse in asthma: a quality improvement project in primary care

Soraia Sultana Islam, Nibras A Zamir, Himanshu Singh, Ramyaa Vijayaratnam, Joshua Daniel, Binu Wickremasinghe, Nabihah Rahman, Aaliya Ashar, Sharon Manoj, Cinzia Prosperi, Vishal Narad, Dania Shoeb und 1 weitere

British Journal of General Practice · 14.05.2026 · 76 (suppl 1) · bjgp26X745581

DOI: 10.3399/bjgp26x745581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of General Practice, online erschienen am 14.05.2026. Verfasst von Soraia Sultana Islam und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Willows Medical Practice, Chigwell, Essex, UK. Hauptthemen laut MEDLINE: Asthma, Quality Improvement, Primary Health Care, Adrenergic beta-2 Receptor Agonists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

National asthma guidelines (National Institute for Health and Care Excellence or British Thoracic Society/Scottish Intercollegiate Guidelines Network) have recently been updated to recommend anti-inflammatory reliever (AIR) and maintenance and reliever therapy (MART) for patients managed on short-acting beta-2 agonist (SABA) inhalers, due to evidence linking SABA overuse with poor asthma outcomes.

Aim

This project aimed to identify patients over-relying on SABA inhalers, assess practice compliance with national guidelines, and implement interventions to optimise management. Interventions included asthma reviews, inhaler technique assessment, and initiating AIR/MART therapy where appropriate.

Method

A two-cycle retrospective audit was conducted, including adult patients issued ≥2 SABA inhalers in the last 12 months.

Results

In the first cycle (October 2024), 94 patients were identified, of which 72 (76.6%) could be contacted and 37 (51.4%) overused their SABA inhaler ≥3 times per week. In the second cycle (September 2025), 35 patients were identified, 23 (65.7%) could be contacted and 18 (78.3%) reported SABA inhaler overuse. Between the two cycles, the number of patients identified as issued ≥2 inhalers over 12 months decreased from 94 to 35 (−62.8%), and SABA inhaler overuse (≥3 times a week) decreased from 37 to 18 (−51.4%).

Conclusion

This project demonstrates that identifying SABA inhaler overuse and implementing updated national guidelines can improve asthma control and prescribing in general practice. This model could be replicated across other primary care practices to improve patient outcomes and reduce healthcare system burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaQuality ImprovementPrimary Health CareAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsPrescription Drug OveruseHumansRetrospective StudiesFemalePractice Guidelines as TopicGuideline AdherenceNebulizers and VaporizersMaleAdultMiddle AgedAdministration, Inhalation

Substanzen

Adrenergic beta-2 Receptor AgonistsAnti-Asthmatic Agents

Autor:innen und Institutionen

  • The Willows Medical Practice, Chigwell, Essex, UK.
  • Department of Medicine, University College London (UCL) Medical School, UCL, London, UK.
  • Department of Medicine, UCL Medical School, UCL, London, UK.
  • Paediatrics, Basildon Hospital, Mid and South Essex NHS Foundation Trust, Essex, UK.
  • Psychiatry, Basildon Hospital, Mid and South Essex NHS Foundation Trust, Essex, UK.
  • Department of Medicine, Barts and The London School of Medicine and Dentistry, London, UK.

Zitieren

APA

Islam, S. S., Zamir, N. A., Singh, H., Vijayaratnam, R., Daniel, J., Wickremasinghe, B., Rahman, N., Ashar, A., Manoj, S., Prosperi, C., Narad, V., Shoeb, D., & Muhammad, S. (2026). Reducing short-acting beta-2 agonist overuse in asthma: a quality improvement project in primary care. British Journal of General Practice, 76(suppl 1), bjgp26X745581. https://doi.org/10.3399/bjgp26x745581

Vancouver

Islam SS, Zamir NA, Singh H, Vijayaratnam R, Daniel J, Wickremasinghe B, et al. Reducing short-acting beta-2 agonist overuse in asthma: a quality improvement project in primary care. British Journal of General Practice. 2026;76(suppl 1):bjgp26X745581. doi:10.3399/bjgp26x745581

BibTeX
@article{Islam2026,
  author = {Islam, Soraia Sultana and Zamir, Nibras A and Singh, Himanshu and Vijayaratnam, Ramyaa and Daniel, Joshua and Wickremasinghe, Binu and Rahman, Nabihah and Ashar, Aaliya and Manoj, Sharon and Prosperi, Cinzia and Narad, Vishal and Shoeb, Dania and Muhammad, Shahrukh},
  title = {Reducing short-acting beta-2 agonist overuse in asthma: a quality improvement project in primary care},
  journal = {British Journal of General Practice},
  year = {2026},
  volume = {76},
  number = {suppl 1},
  pages = {bjgp26X745581},
  doi = {10.3399/bjgp26x745581}
}
Kostenlos starten →